BRTX vs ESS · rev $401.0K vs P/E 31, rev $1.89B
BioRestorative Therapies Inc (BRTX) versus Essex Property Trust Inc (ESS) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported ESS revenue for 2025-12-31 was $1.89B. Net income was $702.8M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
BRTX currently screens at market cap $10.2M. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Not investment advice. Open the BRTX and ESS stock pages for the full models.
Not investment advice.